Ozempic is a prescription medication that contains semaglutide, a synthetic compound designed to mimic the effects of a natural hormone called glucagon-like peptide-1 (GLP-1)
The guidelines, which were based on a review of the available evidence that included 21 clinical trials with data on over 21,000 participants, recommended against treatment unless the patient has overt hypothyroidism, subclinical hypothyroidism with TSH levels greater than 20 lU/mL, is pregnant or trying to become pregnant, or presents other considerations strongly indicating treatment
Appointments start from 25 and are available only after a pharmacist suitability assessment
Tesamorelin: The Visceral Fat Targeter Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone (GHRH)
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al